PrimeRFP SCOUT · Federal Contract Recompete Brief

75N91025C00046PHASE i SBIR concept AWARD for — Gencyte Therapeutics Inc

Gencyte Therapeutics Inc holds $555K across 2 federal awards, concentrated at Department of Health and Human Services (HHS). Competition previously drew 16 offers. Set-aside status: Small business. Recompete timing centers on the May 31, 2027 PoP end — agencies typically plan 12–18 months ahead.

Nih Nci

Awarding office

Gencyte Therapeutics Inc

Recipient

May 31, 2027

PoP end

$500K

Obligated

$500K

Potential

541715

NAICS

AN12

PSC

Small business

Set-aside

16 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Small business

Contract number75N91025C00046

AgencyNih Nci

Awarding officeNih Nci

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentGencyte Therapeutics Inc

CAGE7ZVP4

UEIKLLTVAECBMN8

NAICS541715

PSCAN12

Place of performanceSAN CARLOS CA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition After Exclusion Of Sources

PoP startSep 12, 2025

PoP end (current)May 31, 2027

Obligated$500K

Current value$500K

Potential value$500K

PHASE I SBIR CONCEPT AWARD FOR LOGIC GATED MOLECULAR ADAPTOR SYSTEM FOR JMML TREATMENT is a federal Small business award for Nih Nci held by Gencyte Therapeutics Inc. Estimated value $500K ($500K obligated). Current period of performance ends May 31, 2027. Last award drew 16 bidders. Place of performance: SAN CARLOS CA.

PHASE I SBIR CONCEPT AWARD FOR LOGIC GATED MOLECULAR ADAPTOR SYSTEM FOR JMML TREATMENT

Recompete timing

Public

● Expiring in 246 days

Current PoP ends May 31, 2027 (246 days remaining). Agencies typically plan 12–18 months ahead — at 8.1 months out, that window is already open. The buying decision is likely already in motion.

Bonuses end Sept 30

Want the durability read on 75N91025C00046? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Gencyte Therapeutics Inc — $555K obligated across 2 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$555K · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75N91025C00046?

75N91025C00046 (PHASE i SBIR concept AWARD for) is a Nih Nci award with a potential value of $500K, currently held by Gencyte Therapeutics Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N91025C00046?

Nih Nci awarded 75N91025C00046 to Gencyte Therapeutics Inc (potential $500K).

Who is the incumbent on 75N91025C00046?

Gencyte Therapeutics Inc is the incumbent with $555K across 2 related awards in SCOUT’s public footprint. The current period of performance ends May 31, 2027.

When does Gencyte Therapeutics Inc’s 75N91025C00046 come up for recompete?

SCOUT tracks a period-of-performance end of May 31, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75N91025C00046? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action Jul 16, 2026